
|Videos|November 28, 2019
Dr. Patel on Sequencing Therapy in Rectal Cancer
Author(s)Timil Patel, MD
Timil Patel, MD, discusses an optimal sequencing strategy in rectal cancer.
Advertisement
Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses an optimal sequencing strategy in rectal cancer.
Following chemotherapy, patients are restaged, and a multidisciplinary tumor board recommends next steps based on the patient’s response to systemic chemotherapy, says Patel.
Generally, chemoradiation is recommended for patients with a single site of disease who responded well to chemotherapy. Subsequently, a tumor board will decide whether radiation or surgical resection is the optimal approach to treat lung nodules, concludes Patel.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5




































